Extract from Asteraceae Brachylaena ramiflora induces apoptosis preferentially in mutant p53-expressing human tumor...

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• The p53 tumor suppressor gene is frequently inactivated by mutation in human cancers, promoting tumor growth and therapy resistance.
• Restoring function to mutant p53 is a key therapeutic strategy for cancer treatment.
• Previous work identified a compound that reactivates p53 and induces apoptosis in a mutant p53-dependent manner.

Purpose of the Study:

• To identify and characterize novel therapeutic agents targeting mutant p53.
• To investigate the potential of natural products for cancer therapy.

Main Methods:

• Screening of plant extracts for anti-cancer activity.
• Testing the efficacy of Brachylaena ramiflora extract on human tumor cells expressing mutant p53.
• Induction of apoptosis assays.

Main Results:

• An extract from the terrestrial plant Brachylaena ramiflora selectively induced apoptosis in human tumor cells harboring mutant p53.
• The extract demonstrated preferential activity against cells with p53 mutations.

Conclusions:

• Brachylaena ramiflora extract represents a promising source for novel anti-cancer drug development targeting mutant p53.
• Further investigation into the active compounds within the extract may yield new structural scaffolds for therapeutic agents.